Home » Topics » BioWorld Science

BioWorld Science
RSS

Tissue factor knockout human placenta adherent stromal cells tested in MS model

July 1, 2021

LG Chem patents sphingosine 1-phosphate receptor 1 agonists

July 1, 2021

Somatostatin SST5 receptor antagonists discovered at Kallyope

July 1, 2021

Janssen Pharmaceutica identifies new N-acetyl-beta-D-glucosaminidase inhibitors

July 1, 2021

PB-201 shows safety and dose-dependent glycemic control in phase I trial

July 1, 2021

Albireo describes new inhibitors of IBAT and/or NTCP

July 1, 2021

SwanBio begins natural history study of adrenomyeloneuropathy to support SBT-101 development

July 1, 2021

New antifungals identified at Wigen Biomedicine Technology

July 1, 2021

Saniona begins phase I trial of SAN-711 for neuropathic disorders

June 30, 2021

Alnylam initiates phase II study of zilebesiran for mild to moderate hypertension

June 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...